Approval · Notice of Compliance 9384 · 2008
M.T.E.-4: Notice of Compliance 9384
Issued February 14, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9384
- Date
- February 14, 2008
- Company
- Pharmaceutical Partners Of Canada IncRichmond Hill, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Multi-trace element
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| M.T.E.-4 | 02139278 | Cancelled Post Market |
| M.T.E.-4 CONCENTRATED | 02139251 | Cancelled Post Market |
Medicinal ingredients
- ZINC SULFATE 1 MG per ML
- CUPRIC SULFATE 0.4 MG per ML
- CHROMIC CHLORIDE 4 MCG per ML
- MANGANESE SULFATE 0.1 MG per ML
- ZINC SULFATE 5 MG per ML
- CUPRIC SULFATE 1 MG per ML
- CHROMIC CHLORIDE 10 MCG per ML
- MANGANESE SULFATE 0.5 MG per ML